LR Health & Beauty SE · ISIN: NO0013149658 · EQS - Company News

LR Health & Beauty SE further increases growth trend in the third quarter 

LR Health & Beauty SE further increases growth trend in the third quarter  Sales significantly increased by 7.2% to EUR 69.4 million in the third quarter of 2024 In Q3 2024 EBITDA reported rose to EUR 7.3 million and normalized EBITDA increased to EUR 8.7 million Successful market launch of LR ZEITGARD Signature and realignment of the career plan increased the number of new distributors and led to higher sales Adjusted guidance for 2024: Sales range of EUR 288 million to EUR 292 million,...
About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News LR Health & Beauty SE

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
26 November 2024 12:47PM
LR Health & Beauty SE further increases growth trend in the third quarter 
NO0013149658
LR Health & Beauty SE further increases growth trend in the third quarter  Sales significantly increased by 7.2% to EUR 69.4 million in the third quarter of 2024 In Q3 2024 EBITDA reported rose to EUR 7.3 million and normalized EBITDA increased to EUR 8.7 million Successful market launch of LR ZEITGARD Signature and realignment of the career...
LR Health & Beauty SE
About the publication
26 November 2024 12:45PM
Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year 
NO0013149658
Disclosure of an inside information acc. to Art. 17 of the Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR)  LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year  Ahlen, 26 November 2024 – In the third quarter of 2024 LR Health & Beauty SE (bond,...
LR Health & Beauty SE
About the publication
30 August 2024 07:30AM
LR Health & Beauty SE bestätigt Wachstumstrend im zweiten Quartal 2024
NO0013149658
LR Health & Beauty SE confirms growth trend in the second quarter of 2024 Sales increased to EUR 143.3 million in the first half of 2024   Normalized EBITDA of EUR 14.4 million Rising demand for subscription concepts like the successful LR Health Mission Growth prospects strengthened by innovative product range and planned launch of a new p...
LR Health & Beauty SE
About the publication
28 May 2024 07:30AM
LR Health & Beauty SE delivers good start into the 2024 financial year
NO0013149658
LR Health & Beauty SE delivers good start into the 2024 financial year Sales of EUR 72.6 million in the first quarter of 2024 Normalised EBITDA of EUR 7.8 million Focus on further expansion of innovative product range Digital initiatives progressing successfully Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social...
LR Health & Beauty SE
About the publication
28 May 2024 07:30AM
LR Health & Beauty SE delivers good start into the 2024 financial year
NO0013149658
LR Health & Beauty SE delivers good start into the 2024 financial year Sales of EUR 72.6 million in the first quarter of 2024 Normalised EBITDA of EUR 7.8 million Focus on further expansion of innovative product range Digital initiatives progressing successfully Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social...
LR Health & Beauty SE
About the publication
30 April 2024 07:30AM
LR Health & Beauty SE reports a successful 2023 financial year and expands its innovative product range
NO0013149658
LR Health & Beauty SE reports a successful 2023 financial year and expands its innovative product range Sales increase to EUR 276.5 million; EBITDA reported reaches EUR 31.4 million Digitalisation and sales activities promote partners’ career development Expansion of innovative product range provides for positive business outlook  Ahlen, 30 ...
LR Health & Beauty SE
About the publication
26 March 2024 11:00AM
Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy
NO0013149658
LR Health & Beauty SE: Shareholder Quadriga Capital wins Evoco as major investor / Investors provide additional capital to fund successful growth strategy Quadriga Capital wins Evoco as major investor for LR Health & Beauty Investors support successful growth strategy with additional capital Settlement of New Bond 2024/2028 completed  Ah...
LR Health & Beauty SE
About the publication
More LR Health & Beauty SE related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN